Trials / Conditions / Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Motor Neuron Disease, Amyotrophic Lateral Sclerosis

13 registered clinical trials studyying Motor Neuron Disease, Amyotrophic Lateral Sclerosis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Functional Outcomes and Control Using Synchron BCI - Australia NCT07533903	Synchron, Inc.	N/A
Recruiting	Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With NCT07187388	Nova Southeastern University	N/A
Unknown	Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease NCT06320444	University of Dublin, Trinity College	—
Unknown	Telemonitoring in NIV MND (OptNIVent) NCT05299372	Liverpool University Hospitals NHS Foundation Trust	N/A
Recruiting	Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease NCT05136222	University of Melbourne	N/A
Completed	Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS NCT05852405	Ambulanzpartner Soziotechnologie APST GmbH	—
Recruiting	Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial NCT04302870	University of Edinburgh	Phase 2 / Phase 3
Unknown	NeuroCognitive Communicator: Safety Study NCT03100110	Ottawa Hospital Research Institute	N/A
Completed	Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS NCT03520517	Biohaven Pharmaceuticals, Inc.	Phase 1
Unknown	Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS NCT03604822	Alisa Apreleva	N/A
Recruiting	ALS Research Collaborative NCT06885918	ALS Therapy Development Institute	—
Completed	Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis NCT03828123	Bioinova, s.r.o.	Phase 1 / Phase 2
No Longer Available	Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) NCT03537807	Biohaven Pharmaceuticals, Inc.	—